Figures computed from official regulatory filings — .
Analysttarget 96 USD (+38%) · consensus 3.71/5 · 8 buy · 9 hold · 0 sell
Ownershipinsiders 0.16% · institutions 100.33% · short 4.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Zoetis Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
25 buys215 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| FULLER JULIE | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| FULLER JULIE | Exercise | n/a (No price was disclosed in the filing) | SEC |
| FULLER JULIE | Other | $19.1K | SEC |
| Stetter Mark | AwardD (derivative) | $25K | SEC |
| SACCARO JAMES | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DAMELIO FRANK A | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| FULLER JULIE | AwardD (derivative) | $8.2K | SEC |
| Nayak Abhay U | AwardD (derivative) | $5.6K | SEC |
| JOSEPH WETTENY | AwardD (derivative) | $9.5K | SEC |
| Driscoll Rimma | AwardD (derivative) | $6.2K | SEC |
| Sarbaugh Keith | AwardD (derivative) | $6.8K | SEC |
| Lagano Roxanne | AwardD (derivative) | $8.2K | SEC |
| Esch Kevin | AwardD (derivative) | $8.1K | SEC |
| PECK KRISTIN C | AwardD (derivative) | $16.2K | SEC |
| Ferran Astorga Jeannette | AwardD (derivative) | $1.2K | SEC |
| Stetter Mark | AwardD (derivative) | $25K | SEC |
| MCCALLISTER MICHAEL Btrack record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Stetter Mark | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Stetter Mark | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| PARENT LOUISE M | Exercise | n/a (No price was disclosed in the filing) | SEC |
| PARENT LOUISE M | Exercise | n/a (No price was disclosed in the filing) | SEC |
| PARENT LOUISE M | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PARENT LOUISE M | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BISARO PAULtrack record | Buy | $151.8K | conv 53ClusterFirst in 12mo | SEC |
| DAMELIO FRANK A | Buy | $501.3K | conv 79ClusterUnusual size+1 | SEC |